Cargando…

Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs

Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared w...

Descripción completa

Detalles Bibliográficos
Autores principales: Willett, Julian Daniel Sunday, Lu, Tianyuan, Nakanishi, Tomoko, Yoshiji, Satoshi, Butler-Laporte, Guillaume, Zhou, Sirui, Farjoun, Yossi, Richards, J. Brent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511363/
https://www.ncbi.nlm.nih.gov/pubmed/37640912
http://dx.doi.org/10.1007/s00439-023-02590-w
_version_ 1785108122430341120
author Willett, Julian Daniel Sunday
Lu, Tianyuan
Nakanishi, Tomoko
Yoshiji, Satoshi
Butler-Laporte, Guillaume
Zhou, Sirui
Farjoun, Yossi
Richards, J. Brent
author_facet Willett, Julian Daniel Sunday
Lu, Tianyuan
Nakanishi, Tomoko
Yoshiji, Satoshi
Butler-Laporte, Guillaume
Zhou, Sirui
Farjoun, Yossi
Richards, J. Brent
author_sort Willett, Julian Daniel Sunday
collection PubMed
description Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared with the genetic control of disease risk. This may be because gene expression is measured in the wrong cell type, physiological state, or organ. We tested whether Mendelian randomization (MR) could identify genes at loci influencing COVID-19 outcomes and whether the colocalization of genetic control of expression and COVID-19 outcomes was influenced by cell type, cell stimulation, and organ. We conducted MR of cis-eQTLs from single cell (scRNA-seq) and bulk RNA sequencing. We then tested variables that could influence colocalization, including cell type, cell stimulation, RNA sequencing modality, organ, symptoms of COVID-19, and SARS-CoV-2 status among individuals with symptoms of COVID-19. The outcomes used to test colocalization were COVID-19 severity and susceptibility as assessed in the Host Genetics Initiative release 7. Most transcripts identified using MR did not colocalize when tested across cell types, cell state and in different organs. Most that did colocalize likely represented false positives due to linkage disequilibrium. In general, colocalization was highly variable and at times inconsistent for the same transcript across cell type, cell stimulation and organ. While we identified factors that influenced colocalization for select transcripts, identifying 33 that mediate COVID-19 outcomes, our study suggests that colocalization of expression with COVID-19 outcomes is partially due to noisy signals even after following quality control and sensitivity testing. These findings illustrate the present difficulty of linking expression transcripts to disease outcomes and the need for skepticism when observing eQTL MR results, even accounting for cell types, stimulation state and different organs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-023-02590-w.
format Online
Article
Text
id pubmed-10511363
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105113632023-09-22 Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs Willett, Julian Daniel Sunday Lu, Tianyuan Nakanishi, Tomoko Yoshiji, Satoshi Butler-Laporte, Guillaume Zhou, Sirui Farjoun, Yossi Richards, J. Brent Hum Genet Original Investigation Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared with the genetic control of disease risk. This may be because gene expression is measured in the wrong cell type, physiological state, or organ. We tested whether Mendelian randomization (MR) could identify genes at loci influencing COVID-19 outcomes and whether the colocalization of genetic control of expression and COVID-19 outcomes was influenced by cell type, cell stimulation, and organ. We conducted MR of cis-eQTLs from single cell (scRNA-seq) and bulk RNA sequencing. We then tested variables that could influence colocalization, including cell type, cell stimulation, RNA sequencing modality, organ, symptoms of COVID-19, and SARS-CoV-2 status among individuals with symptoms of COVID-19. The outcomes used to test colocalization were COVID-19 severity and susceptibility as assessed in the Host Genetics Initiative release 7. Most transcripts identified using MR did not colocalize when tested across cell types, cell state and in different organs. Most that did colocalize likely represented false positives due to linkage disequilibrium. In general, colocalization was highly variable and at times inconsistent for the same transcript across cell type, cell stimulation and organ. While we identified factors that influenced colocalization for select transcripts, identifying 33 that mediate COVID-19 outcomes, our study suggests that colocalization of expression with COVID-19 outcomes is partially due to noisy signals even after following quality control and sensitivity testing. These findings illustrate the present difficulty of linking expression transcripts to disease outcomes and the need for skepticism when observing eQTL MR results, even accounting for cell types, stimulation state and different organs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-023-02590-w. Springer Berlin Heidelberg 2023-08-28 2023 /pmc/articles/PMC10511363/ /pubmed/37640912 http://dx.doi.org/10.1007/s00439-023-02590-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Investigation
Willett, Julian Daniel Sunday
Lu, Tianyuan
Nakanishi, Tomoko
Yoshiji, Satoshi
Butler-Laporte, Guillaume
Zhou, Sirui
Farjoun, Yossi
Richards, J. Brent
Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
title Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
title_full Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
title_fullStr Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
title_full_unstemmed Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
title_short Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
title_sort colocalization of expression transcripts with covid-19 outcomes is rare across cell states, cell types and organs
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511363/
https://www.ncbi.nlm.nih.gov/pubmed/37640912
http://dx.doi.org/10.1007/s00439-023-02590-w
work_keys_str_mv AT willettjuliandanielsunday colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT lutianyuan colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT nakanishitomoko colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT yoshijisatoshi colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT butlerlaporteguillaume colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT zhousirui colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT farjounyossi colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans
AT richardsjbrent colocalizationofexpressiontranscriptswithcovid19outcomesisrareacrosscellstatescelltypesandorgans